Covalon Technologies Ltd.

TSXV:COV Stock Report

Market Cap: CA$92.9m

Covalon Technologies Future Growth

Future criteria checks 1/6

Covalon Technologies is forecast to grow revenue at 9.9% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth33.8%
Revenue growth rate9.9%
Future return on equity11.1%
Analyst coverage

Low

Last updated05 Dec 2024

Recent future growth updates

No updates

Recent updates

Subdued Growth No Barrier To Covalon Technologies Ltd. (CVE:COV) With Shares Advancing 29%

Nov 17
Subdued Growth No Barrier To Covalon Technologies Ltd. (CVE:COV) With Shares Advancing 29%

Covalon Technologies Ltd.'s (CVE:COV) 25% Share Price Surge Not Quite Adding Up

Aug 18
Covalon Technologies Ltd.'s (CVE:COV) 25% Share Price Surge Not Quite Adding Up

We Think Covalon Technologies (CVE:COV) Can Afford To Drive Business Growth

Aug 10
We Think Covalon Technologies (CVE:COV) Can Afford To Drive Business Growth

Optimistic Investors Push Covalon Technologies Ltd. (CVE:COV) Shares Up 83% But Growth Is Lacking

Jun 16
Optimistic Investors Push Covalon Technologies Ltd. (CVE:COV) Shares Up 83% But Growth Is Lacking

Covalon Technologies (CVE:COV) Is In A Good Position To Deliver On Growth Plans

May 01
Covalon Technologies (CVE:COV) Is In A Good Position To Deliver On Growth Plans

Covalon Technologies Ltd.'s (CVE:COV) Price Is Right But Growth Is Lacking After Shares Rocket 25%

Feb 17
Covalon Technologies Ltd.'s (CVE:COV) Price Is Right But Growth Is Lacking After Shares Rocket 25%

Insufficient Growth At Covalon Technologies Ltd. (CVE:COV) Hampers Share Price

Dec 22
Insufficient Growth At Covalon Technologies Ltd. (CVE:COV) Hampers Share Price

We Think Covalon Technologies (CVE:COV) Can Afford To Drive Business Growth

Sep 02
We Think Covalon Technologies (CVE:COV) Can Afford To Drive Business Growth

We Think Covalon Technologies (CVE:COV) Needs To Drive Business Growth Carefully

May 26
We Think Covalon Technologies (CVE:COV) Needs To Drive Business Growth Carefully

Is Covalon Technologies (CVE:COV) Using Too Much Debt?

Apr 29
Is Covalon Technologies (CVE:COV) Using Too Much Debt?

Covalon Technologies (CVE:COV) Is Making Moderate Use Of Debt

Dec 29
Covalon Technologies (CVE:COV) Is Making Moderate Use Of Debt

Earnings and Revenue Growth Forecasts

TSXV:COV - Analysts future estimates and past financials data (CAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202743N/AN/A41
9/30/202640N/AN/A31
9/30/202536N/AN/A11
9/30/202432N/AN/A31
6/30/202429-111N/A
3/31/202426-3-3-2N/A
12/31/202325-5-4-3N/A
9/30/202327-4-5-3N/A
6/30/202325-6-6-5N/A
3/31/202323-7-9-8N/A
12/31/202219-9-10-8N/A
9/30/202218-9-9-8N/A
6/30/202219-4-8-8N/A
3/31/202221-2-4-3N/A
12/31/202122000N/A
9/30/202120000N/A
6/30/20217-411N/A
3/31/20217-411N/A
12/31/20208-800N/A
9/30/202014-8-4-4N/A
6/30/202026-8-3-3N/A
3/31/202027-12-4-4N/A
12/31/201935-8-5-4N/A
9/30/201934-9-4-3N/A
6/30/201934-6-3-2N/A
3/31/201935-1-3-2N/A
12/31/201828-1-5-4N/A
9/30/2018272-1-1N/A
6/30/2018303-1-1N/A
3/31/2018281N/A-1N/A
12/31/2017282N/A0N/A
9/30/2017272N/A0N/A
6/30/201718-1N/A-2N/A
3/31/201715-1N/A-1N/A
12/31/201610-3N/A-1N/A
9/30/20167-3N/A-1N/A
6/30/20168-2N/A-3N/A
3/31/20167-2N/A-3N/A
12/31/201590N/A-3N/A
9/30/20158-1N/A-2N/A
6/30/20157-1N/A-1N/A
3/31/20156-1N/A-1N/A
12/31/20146-1N/A-1N/A
9/30/201492N/A3N/A
6/30/201493N/A3N/A
3/31/2014104N/A3N/A
12/31/201383N/A3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if COV's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if COV's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if COV's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: COV's revenue (9.9% per year) is forecast to grow faster than the Canadian market (7.3% per year).

High Growth Revenue: COV's revenue (9.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: COV's Return on Equity is forecast to be low in 3 years time (11.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 22:34
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Covalon Technologies Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andre UddinResearch Capital Corporation